The Benzodiazepine Controversy: Therapeutic Effects versus Dependence, Withdrawal, and Toxicity

References

• American Psychiatric Association Task Force on Benzodiazepine Dependency. Benzodiazepine dependence, toxicity, and abuse. American Psychiatric Press, Washington, DC 1990
   Google Scholar
• Shader R I, Greenblatt D J. Use of benzodiazepines in anxiety disorders. N Engl J Med 1993; 328: 1398–405
   PubMed Web of Science ®Google Scholar
• Shader R I, Greenblatt D J, Balter M B. Appropriate use and regulatory control of benzodiazepines. J Clin Pharmacol 1991; 31: 781–4
   PubMedGoogle Scholar
• Griffiths R R. Commentary on review by Woods and Winger: Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial. Psychopharmacology 1995; 118: 116–7
   Web of Science ®Google Scholar
• Lader M. Commentary on review by Woods and Winger entitled “Current benzodiazepine issues.”. Psychopharmacology 1995; 118: 118
   Google Scholar
• Lader M, Morton S. Benzodiazepine problems. Br J Addict 1991; 86: 823–8
   PubMedGoogle Scholar
• Tyrer P. Current problems with the benzodiazepines. The anxiolytic jungle: where next?, D Wheatley. Wiley, ChichesterEngland 1990; 24–36
   Google Scholar
• Woods J H, Winger G. Current benzodiazepine issues. Psychopharmacology 1995; 118: 107–15
   PubMed Web of Science ®Google Scholar
• Woods J, Winger G. Rebuttal of comments by Griffiths, Lader and Greenblatt to review by Woods and Winger. Psychopharmacology 1995; 118: 120–1
   Google Scholar
• Balter M B, Ban T A, Uhlenhuth E H. International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications, I: Current concerns. Hum Psychopharmacol 1993; 8: 253–61
   Google Scholar
• Ciraulo D A, Sarid-Segal O. Benzodiazepines: abuse liability. Benzodiazepines in clinical practice: risks and benefits, P P Roy-Byrne, D S Cowley. American Psychiatric Press, Washington, DC 1991; 157–74
   Google Scholar
• Griffiths R R, Wolf B. Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 1990; 10: 237–43
   PubMed Web of Science ®Google Scholar
• Salzman C. Issues and controversies regarding benzodiazepine use. NIDA Res Monogr 1993; 131: 68–89
   Google Scholar
• Woods J H, Katz J L, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992; 44: 151–347
   PubMed Web of Science ®Google Scholar
• Reidenberg M M. Effect of the requirement for triplicate prescriptions for benzodiazepines in New York State. Clin Pharmacol Ther 1991; 50: 129–1
   Google Scholar
• Hoffman R S, Wipfler M G, Maddaloni M A, Weisman R S. Has the New York State triplicate benzodiazepine prescription regulation influenced sedative-hypnotic overdoses?. N Y State J Med 1991; 91: 436–9
   Google Scholar
• Schwartz H I, Blank K. Regulation of benzodiazepine prescribing practices: clinical implications. Gen Hosp Psychiatry 1991; 13: 219–24
   Google Scholar
• Petursson H. An international perspective on benzodiazepine abuse. Benzodiazepine dependence, C Hallström. Oxford University Press, OxfordEngland 1993; 186–202
   Google Scholar
• Cowley D S, Roy-Byrne P P, Greenblatt D J, Hommer D W. Personality and benzodiazepine sensitivity in anxious patients and control subjects. Psychiatry Res 1993; 47: 151–62
   PubMed Web of Science ®Google Scholar
• Schweizer E, Rickels K, Case G, Greenblatt D J. Long-term therapeutic use of benzodiazepines. Arch Gen Psychiatry 1990; 47: 908–15
   PubMed Web of Science ®Google Scholar
• Fernandez F, Levy J K. Use of benzodiazepines in the medically ill. Benzodiazepines in clinical practice: risks and benefits, P P Roy-Byrne. American Psychiatric Press, Washington, DC 1991; 177–200
   Google Scholar
• Salzman C. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. J Psychiatr Res 1993; 27: 97–110
   PubMed Web of Science ®Google Scholar
• Barnas C, Whitworth A B, Fleischhacker W W. Are patterns of benzodiazepine use predictable: a follow-up study of benzodiazepine users. Psychopharmacology 1993; 111: 301–5
   Google Scholar
• Wright N, Caplan R, Payne S. Community survey of long term daytime use of benzodiazepines. BMJ 1994; 309: 27–8
   PubMed Web of Science ®Google Scholar
• King M B, Gabe J, Williams P, Rodrigo E K. Long term use of benzodiazepines: the views of patients. Br J Gen Pract 1990; 40: 194–6
   PubMed Web of Science ®Google Scholar
• Salinsky J V, Dore C J. Characteristics of long term benzodiazepine users in general practice. J R Coll Gen Pract 1987; 37: 202–4
   PubMedGoogle Scholar
• Mellinger G D, Balter M B, Uhlenhuth E H. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984; 251: 375–9
   PubMed Web of Science ®Google Scholar
• Salzman C. Treatment of anxiety. Clinical geriatric psychopharmacology. 2nd ed., C Salzman. Williams & Wilkins, Baltimore 1992; 189–214
   Google Scholar
• Tönne U, Hiltunen A J, Vikander B, Engelbrektsson K, Bergman H, Bergman I, et al. Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatr Scand 1995; 91: 299–304
   PubMedGoogle Scholar
• Salzman C, Fisher J, Nobel K, Glassman R, Wolfson A, Kelley M. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7: 89–93
   Web of Science ®Google Scholar
• Smith B D, Salzman C. Do benzodiazepines cause depression?. Hosp Community Psychiatry 1991; 42: 1101–2
   PubMedGoogle Scholar
• Salzman C, Watsky E. Rational prescribing of benzodiazepines. Benzodiazepine dependence, C Hallström. Oxford University Press, OxfordEngland 1993; 13–33
   Google Scholar